Genetically correlated effects of selective breeding for high and low methamphetamine consumption

Genes, Brain and Behavior

Volumn 8, Issue 8, 2009, Pages 758-771

  Wheeler, J M ^a,b   Reed, C ^a,b   Burkhart Kasch, S ^a,b   Li, N ^a,b   Cunningham, C L ^a,b   Janowsky, A ^a,b,c   Franken, F H ^a,b   Wiren, K M ^a,c   Hashimoto, J G ^c   Scibelli, A C ^a,b   Phillips, T J ^a,b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b Department of Behavioral Neuroscience ^*  (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Addiction; Conditioned place preference; Conditioned taste aversion; Drug reward; EQTL; Gene expression; Preference drinking; Selective breeding

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHAMPHETAMINE; PROTEIN FOS; PSYCHOSTIMULANT AGENT; SEROTONIN 3A RECEPTOR; SEROTONIN TRANSPORTER;

ALLOSTASIS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BREEDING; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; INTRAVENOUS ADMINISTRATION; MALE; MOTIVATION; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD; SIGNAL TRANSDUCTION; TASTE AVERSION;

ADMINISTRATION, ORAL; AMPHETAMINE-RELATED DISORDERS; ANIMALS; APOPTOSIS; AVOIDANCE LEARNING; BREEDING; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; IMMUNE SYSTEM; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MOTIVATION; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-REL; RECEPTORS, SEROTONIN, 5-HT3; SELF ADMINISTRATION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

MUS;

EID: 70449337630     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2009.00522.x     Document Type: Article

References (53)

1. Aguilar, M.A., Rodriguez-Arias, M. & Minarro, J. (2009) Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 59, 253 277.
2. Akilesh, S., Shaffer, D.J. & Roopenian, D. (2003) Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. Genome Res 13, 1719 1727.
3. Ang, E., Chen, J., Zagouras, P., Magna, H., Holland, J., Schaeffer, E. & Nestler, E.J. (2001) Induction of nuclear factor-κB in nucleus accumbens by chronic cocaine administration. J Neurochem 79, 221 224.
4. Asanuma, M. & Cadet, J.L. (1998) Methamphetamine-induced increase in striatal NF-κB DNA-binding activity is attenuated in superoxide dismutase transgenic mice. Brain Res Mol Brain Res 60, 305 309.
5. Bardo, M.T. & Bevins, R.A. (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153, 31 43.
6. Bechtholt, A.J., Smith, R., Raber, J. & Cunningham, C.L. (2004) Enhanced ethanol-, but not cocaine-induced, conditioned place preference in Apoe(-/-) mice. Pharmacol Biochem Behav 77, 783 792.
7. Belknap, J.K., Richards, S.P., O'Toole, L.A., Helms, M.L. & Phillips, T.J. (1997) Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. Behav Genet 27, 55 66.
8. Cadet, J.L., Jayanthi, S. & Deng, X. (2003) Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J 17, 1775 1788.
9. Cai, N.S., McCoy, M.T., Ladenheim, B., Lyles, J., Ali, S.F. & Cadet, J.L. (2006) Serial analysis of gene expression in the rat striatum following methamphetamine administration. Ann N Y Acad Sci 1074, 13 30.
10. Crabbe, J.C., Phillips, T.J., Buck, K.J., Cunningham, C.L. & Belknap, J.K. (1999) Identifying genes for alcohol and drug sensitivity: recent progress and future directions. Trends Neurosci 22, 173 179.
11. Cunningham, C.L., Gremel, C.M. & Groblewski, P.A. (2006) Drug-induced conditioned place preference and aversion in mice. Nat Protoc 1, 1662 1670.
12. Cunningham, C. & Noble, D. (1992) Methamphetamine-induced conditioned place preference or aversion depending on dose and presence of drug. Ann N Y Acad Sci 654, 431 433.
13. Deng, X., Ladenheim, B., Tsao, L.I. & Cadet, J.L. (1999) Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity. J Neurosci 19, 10107 10115.
14. Eyerman, D.J. & Yamamoto, B.K. (2007) A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine. J Neurochem 103, 1219 1227.
15. Falconer, D.S. & Mackay, T.F.C. (1996) Introduction to Quantitative Genetics, 4th edn. Longman Group, Essex.
16. Fehr, C., Shirley, R.L., Crabbe, J.C., Belknap, J.K., Buck, K.J. & Phillips, T.J. (2005) The syntaxin binding protein 1 gene (Stxbp1) is a candidate for an ethanol preference drinking locus on mouse chromosome 2. Alcohol Clin Exp Res 29, 708 720.
17. Ferguson, S.M., Fasano, S., Yang, P., Brambilla, R. & Robinson, T.E. (2006) Knockout of ERK1 enhances cocaine-evoked immediate early gene expression and behavioral plasticity. Neuropsychopharmacology 31, 2660 2668.
18. Fidler, T.L., Clews, T.W. & Cunningham, C.L. (2006) Reestablishing an intragastric ethanol self-infusion model in rats. Alcohol Clin Exp Res 30, 414 428.
19. Fidler, T.L., Powers, M.S., Ramirez, J.J. & Cunningham, C.L. (2008) Optimizing passive infusion parameters to produce ethanol self-infusion in C57BL/6J and DBA/2J mice. Alcohol Clin Exp Res 32 ((Suppl.) 215A.
20. Franklin, K.B.J. & Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA, USA.
21. Fumagalli, F., Gainetdinov, R.R., Wang, Y.M., Valenzano, K.J., Miller, G.W. & Caron, M.G. (1999) Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci 19, 2424 2431.
22. Girault, J.A., Valjent, E., Caboche, J. & Herve, D. (2007) ERK2: a logical AND gate critical for drug-induced plasticity? Curr Opin Pharmacol 7, 77 85.
23. Hill, K.G., Ryabinin, A.E. & Cunningham, C.L. (2007) FOS expression induced by an ethanol-paired conditioned stimulus. Pharmacol Biochem Behav 87, 208 221.
24. Huang, D.W., Sherman, B.T., Tan, Q., Kir, J., Liu, D., Bryant, D., Guo, Y., Stephens, R., Baseler, M.W., Lane, H.C. & Lempicki, R.A. (2007) DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 35, W169 W175.
25. Ikeda, M., Ozaki, N., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kishi, T., Sekine, Y., Iyo, M., Harano, M., Komiyama, T., Yamada, M., Sora, I., Ujike, H., Inada, T. & Iwata, N. (2007) Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia. Genes Brain Behav 6, 107 112.
26. Jayanthi, S., Deng, X., Ladenheim, B., McCoy, M.T., Cluster, A., Cai, N. & Cadet, J.L. (2005) Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc Natl Acad Sci U S A 102, 868 873.
27. Kamens, H.M., Burkhart-Kasch, S., McKinnon, C.S., Li, N., Reed, C. & Phillips, T.J. (2005) Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine. Genes Brain Behav 4, 110 125.
28. Kirstein, S.L., Davidson, K.L., Ehringer, M.A., Sikela, J.M., Erwin, V.G. & Tabakoff, B. (2002) Quantitative trait loci affecting initial sensitivity and acute functional tolerance to ethanol-induced ataxia and brain cAMP signaling in BXD recombinant inbred mice. J Pharmacol Exp Ther 302, 1238 1245.
29. Koob, G.F. & Le Moal, M. (2008) Addiction and the brain antireward system. Annu Rev Psychol 59, 29 53.
30. Kovacs, K.J. (2008) Measurement of immediate-early gene activation-c-fos and beyond. J Neuroendocrinol 20, 665 672.
31. Lessov, C.N., Risinger, F.O. & Phillips, T.J. (2001) Attenuation of ethanol-induced conditioned taste aversion in mice sensitized to the locomotor stimulant effects of ethanol. Behav Neurosci 115, 146 153.
32. Meisch, R.A. (2001) Oral drug self-administration: an overview of laboratory animal studies. Alcohol 24, 117 128.
33. Mizoguchi, H., Yamada, K., Mizuno, M., Mizuno, T., Nitta, A., Noda, Y. & Nabeshima, T. (2004) Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-like gene-1 signaling pathway via the activation of dopamine receptors. Mol Pharmacol 65, 1293 1301.
34. Mori, T., Ito, S., Narita, M., Suzuki, T. & Sawaguchi, T. (2004) Combined effects of psychostimulants and morphine on locomotor activity in mice. J Pharmacol Sci 96, 450 458.
35. Morita, Y., Ujike, H., Tanaka, Y., Kishimoto, M., Okahisa, Y., Kotaka, T., Harano, M., Inada, T., Komiyama, T., Hori, T., Yamada, M., Sekine, Y., Iwata, N., Iyo, M., Sora, I., Ozaki, N. & Kuroda, S. (2008) The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorder. Am J Med Genet B Neuropsychiatr Genet 147B, 54 58.
36. Nestler, E.J. (2004) Molecular mechanisms of drug addiction. Neuropharmacology 47 (Suppl 1 24 32.
37. Niwa, M., Nitta, A., Mizoguchi, H., Ito, Y., Noda, Y., Nagai, T. & Nabeshima, T. (2007) A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference. J Neurosci 27, 7604 7615.
38. Otani, K., Ujike, H., Sakai, A., Okahisa, Y., Kotaka, T., Inada, T., Harano, M., Komiyama, T., Hori, T., Yamada, M., Sekine, Y., Iwata, N., Iyo, M., Sora, I., Ozaki, N. & Kuroda, S. (2008) Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence. Neurosci Lett 434, 88 92.
39. Palmer, A.A., Verbitsky, M., Suresh, R., Kamens, H.M., Reed, C.L., Li, N., Burkhart-Kasch, S., McKinnon, C.S., Belknap, J.K., Gilliam, T.C. & Phillips, T.J. (2005) Gene expression differences in mice divergently selected for methamphetamine sensitivity. Mamm Genome 16, 291 305.
40. Phillips, T.J., Huson, M.G. & McKinnon, C.S. (1998) Localization of genes mediating acute and sensitized locomotor responses to cocaine in BXD/Ty recombinant inbred mice. J Neurosci 18, 3023 3034.
41. Phillips, T.J., Broadbent, J., Burkhart-Kasch, S., Henderson, C., Wenger, C.D., McMullin, C., McKinnon, C.S. & Cunningham, C.L. (2005) Genetic correlational analyses of ethanol reward and aversion phenotypes in short-term selected mouse lines bred for ethanol drinking or ethanol-induced conditioned taste aversion. Behav Neurosci 119, 892 910.
42. Phillips, T.J., Kamens, H.M. & Wheeler, J.M. (2008) Behavioral genetic contributions to the study of addiction-related amphetamine effects. Neurosci Biobehav Rev 32, 707 759.
43. Risinger, F.O. & Cunningham, C.L. (1992) Genetic differences in ethanol-induced hyperglycemia and conditioned taste aversion. Life Sci 50, PL113 PL118.
44. Russo, S.J., Mazei-Robison, M.S., Ables, J.L. & Nestler, E.J. (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56 ((Suppl. 1) 73 82.
45. Sanchis-Segura, C. & Spanagel, R. (2006) Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 11, 2 38.
46. Sharpe, A.L., Coste, S.C., Burkhart-Kasch, S., Li, N., Stenzel-Poore, M.P. & Phillips, T.J. (2005) Mice deficient in corticotropin-releasing factor receptor type 2 exhibit normal ethanol-associated behaviors. Alchohol Clin Exp Res 29, 1601 1609.
47. Sulzer, D., Sonders, M.S., Poulsen, M.W. & Galli, A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75, 406 433.
48. Tsuang, M.T., Lyons, M.J., Harley, R.M., Xian, H., Eisen, S., Goldberg, J., True, W.R. & Faraone, S.V. (1999) Genetic and environmental influences on transitions in drug use. Behav Genet 29, 473 479.
49. Turek, V.F., Bennett, B. & Ryabinin, A.E. (2008) Differences in the urocortin 1 system between long-sleep and short-sleep mice. Genes Brain Behav 7, 113 119.
50. Uhl, G.R., Drgon, T., Liu, Q.R., Johnson, C., Walther, D., Komiyama, T., Harano, M., Sekine, Y., Inada, T., Ozaki, N., Iyo, M., Iwata, N., Yamada, M., Sora, I., Chen, C.K., Liu, H.C., Ujike, H. & Lin, S.K. (2008) Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry 65, 345 355.
51. Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J.C., Stipanovich, A., Caboche, J., Lombroso, P.J., Nairn, A.C., Greengard, P., Herve, D. & Girault, J.A. (2005) Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A 102, 253 254.
52. Volkow, N.D., Chang, L., Wang, G.J., Fowler, J.S., Franceschi, D., Sedler, M., Gatley, S.J., Miller, E., Hitzemann, R., Ding, Y.S. & Logan, J. (2001) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21, 9414 9418.
53. Zhai, H., Li, Y., Wang, X. & Lu, L. (2008) Drug-induced alteration in the extracellular signal-regulated kinase (ERK) signaling pathway: implications for reinforcement and reinstatement. Cell Mol Neurobiol 28, 157 172.